These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 18430123

  • 21. Carbonic anhydrase IX as a potential biomarker of efficacy in metastatic clear-cell renal cell carcinoma patients receiving sorafenib or placebo: analysis from the treatment approaches in renal cancer global evaluation trial (TARGET).
    Choueiri TK, Cheng S, Qu AQ, Pastorek J, Atkins MB, Signoretti S.
    Urol Oncol; 2013 Nov; 31(8):1788-93. PubMed ID: 23141780
    [Abstract] [Full Text] [Related]

  • 22. Role of carbonic anhydrase IX, α-methylacyl coenzyme a racemase, cytokeratin 7, and galectin-3 in the evaluation of renal neoplasms: a tissue microarray immunohistochemical study.
    Bing Z, Lal P, Lu S, Ziober A, Tomaszewski JE.
    Ann Diagn Pathol; 2013 Feb; 17(1):58-62. PubMed ID: 22898056
    [Abstract] [Full Text] [Related]

  • 23. Expression and diagnostic implications of carbonic anhydrase IX in several tumours with predominantly clear cell morphology.
    Lin XY, Zhang H, Tang N, Zhang XP, Zhang W, Wang EH, Han YC.
    Histopathology; 2015 Apr; 66(5):685-94. PubMed ID: 25431204
    [Abstract] [Full Text] [Related]

  • 24. Prognostic impact of carbonic anhydrase IX expression in human renal cell carcinoma.
    Sandlund J, Oosterwijk E, Grankvist K, Oosterwijk-Wakka J, Ljungberg B, Rasmuson T.
    BJU Int; 2007 Sep; 100(3):556-60. PubMed ID: 17608827
    [Abstract] [Full Text] [Related]

  • 25. Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma.
    Leibovich BC, Sheinin Y, Lohse CM, Thompson RH, Cheville JC, Zavada J, Kwon ED.
    J Clin Oncol; 2007 Oct 20; 25(30):4757-64. PubMed ID: 17947723
    [Abstract] [Full Text] [Related]

  • 26. Carbonic anhydrase IX expression in clear cell renal cell carcinomas negatively correlates with the proportion of the granular cell component.
    Skapa P, Hyrsl L, Zavada J, Soukup J, Zamecnik J.
    J Clin Oncol; 2008 Aug 01; 26(22):3809-11; author reply 3811-2. PubMed ID: 18669473
    [No Abstract] [Full Text] [Related]

  • 27. [Clear cell papillary renal cell carcinoma: report of a case].
    Lin D, Zhang W, Zhao H, Xin F, Li Y, Liu H.
    Zhonghua Bing Li Xue Za Zhi; 2014 Mar 01; 43(3):192-3. PubMed ID: 24842020
    [No Abstract] [Full Text] [Related]

  • 28. Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnosis, prognosis and treatment.
    Tostain J, Li G, Gentil-Perret A, Gigante M.
    Eur J Cancer; 2010 Dec 01; 46(18):3141-8. PubMed ID: 20709527
    [Abstract] [Full Text] [Related]

  • 29. Soluble carbonic anhydrase IX is not an independent prognostic factor in human renal cell carcinoma.
    Papworth K, Sandlund J, Grankvist K, Ljungberg B, Rasmuson T.
    Anticancer Res; 2010 Jul 01; 30(7):2953-7. PubMed ID: 20683038
    [Abstract] [Full Text] [Related]

  • 30. Dual-pharmacophore DNA-encoded chemical libraries.
    Scheuermann J, Neri D.
    Curr Opin Chem Biol; 2015 Jun 01; 26():99-103. PubMed ID: 25779969
    [Abstract] [Full Text] [Related]

  • 31. Kidney cancer: Carbonic anhydrase IX in resected clear cell RCC.
    Pickering LM, Larkin J.
    Nat Rev Urol; 2015 Jun 01; 12(6):309-10. PubMed ID: 26032554
    [No Abstract] [Full Text] [Related]

  • 32. Carbonic anhydrase expression in kidney and renal cancer: implications for diagnosis and treatment.
    Oosterwijk E.
    Subcell Biochem; 2014 Jun 01; 75():181-98. PubMed ID: 24146380
    [Abstract] [Full Text] [Related]

  • 33. Carbonic anhydrase IX expression in renal neoplasms: correlation with tumor type and grade.
    Genega EM, Ghebremichael M, Najarian R, Fu Y, Wang Y, Argani P, Grisanzio C, Signoretti S.
    Am J Clin Pathol; 2010 Dec 01; 134(6):873-9. PubMed ID: 21088149
    [Abstract] [Full Text] [Related]

  • 34. [Immunohistochemical expression of microvascular density and carbonic anhidrase IX in renal carcinoma. Relation to histological type and tumoral progression].
    Rubio-Briones J, Calatrava A, Fernández-Serra A, Ramos Ruiz R, Iborra I, García-Casado Z, Rubio L, Trassierra M, Collado A, Casanova J, Gómez-Ferrer A, Solsona E, López-Guerrero JA.
    Actas Urol Esp; 2011 Feb 01; 35(2):80-6. PubMed ID: 21256634
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Deal watch: Phase III antibody targeting tumour pH acquired in Prometheus deal.
    Nat Rev Drug Discov; 2011 Jul 01; 10(7):482. PubMed ID: 21720396
    [No Abstract] [Full Text] [Related]

  • 37. Carbonic anhydrase IX is expressed in mesothelioma and metastatic clear cell renal cell carcinoma of the lung.
    Ramsey ML, Yuh BJ, Johnson MT, Yeldandi AV, Zynger DL.
    Virchows Arch; 2012 Jan 01; 460(1):89-93. PubMed ID: 22143934
    [Abstract] [Full Text] [Related]

  • 38. Carbonic anhydrase IX/G250/MN: a molecule too good to be true?
    Oosterwijk E.
    BJU Int; 2008 Mar 01; 101(5):527-8. PubMed ID: 18257853
    [No Abstract] [Full Text] [Related]

  • 39. [Detection of carbonic anhydrase IX gene expression in renal cell carcinoma with reverse transcription-PCR].
    Jiang YD, Zheng SB, Wang ZH.
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Jan 01; 24(1):99-101. PubMed ID: 14724112
    [Abstract] [Full Text] [Related]

  • 40. CA9 as a molecular marker for differential diagnosis of cystic renal tumors.
    Li G, Bilal I, Gentil-Perret A, Feng G, Zhao A, Peoc'h M, Genin C, Tostain J, Gigante M.
    Urol Oncol; 2012 Jan 01; 30(4):463-8. PubMed ID: 20822935
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.